SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 273 filers reported holding SAGE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $3,477,000 | -67.9% | 36,300 | -84.6% | 0.06% | -48.0% |
| Q3 2016 | $10,840,000 | +70.8% | 235,400 | +56.9% | 0.12% | +92.2% |
| Q3 2015 | $6,348,000 | -42.0% | 149,999 | -0.0% | 0.06% | -20.0% |
| Q2 2015 | $10,950,000 | -47.1% | 150,000 | -63.6% | 0.08% | -54.8% |
| Q1 2015 | $20,712,000 | +37.2% | 412,335 | 0.0% | 0.18% | +22.9% |
| Q4 2014 | $15,091,000 | -10.8% | 412,335 | -23.3% | 0.14% | -18.6% |
| Q3 2014 | $16,926,000 | – | 537,335 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |